Search Results 31-40 of 10534 for Lupus
Clinical Trials · Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V · More about research at Mayo Clinic.
Diagnosis of discoid/subacute cutaneous lupus erythematosus (DLE/SCLE) for at least 3 months prior to screening visit. · Meets both clinical and ...
About this study. This is a multi-center, double-blind, randomized, Phase 2b trial to evaluate the efficacy of atacicept in subjects with systemic lupus ...
Plus, why lupus can be difficult to diagnose. Reporter Vivien Williams has more. Journalists: Video is available in the downloads. [TRT 1:04] Click here for ...
The purpose of this study is to evaluate the effectiveness and safety of deucravacitinib compared with placebo in an active moderate to severe Systemic Lupus ...
However, this medicine is not used to treat severe or complicated malaria. Hydroxychloroquine is used to treat discoid lupus erythematosus (DLE) or systemic ...
Lupus. A chronic inflammatory disease, systemic lupus erythematosus can affect many parts of your body, including your skin, joints, kidneys, blood cells, heart ...
The purpose of this study is to investigate the role of nailfold capillaroscopy in the assessment of patients with Systemic Lupus Erythematosus (SLE).
... lupus nephritis in patients who are also receiving other lupus treatments. It is a monoclonal antibody that changes the immune system to help control lupus ...
... lupus erythematosus (CLE) or systemic lupus erythematosus (SLE) showing some skin symptoms. Participation eligibility. Participant eligibility includes age ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your Annual Fund gift can drive advancements in cancer care.